Retatrutide low energy is a common side effect in clinical trials. Learn why fatigue happens, how long it lasts, and practical ways to feel more like yourself.
Low energy is one of the most commonly reported side effects of retatrutide in clinical trials, and it usually appears after a dose increase or during the first few weeks of treatment. The tiredness typically traces back to a sharp drop in calorie intake, gastrointestinal side effects such as nausea, and the drug's triple-hormone mechanism acting on metabolism. Retatrutide is still an investigational medication, so anyone dealing with persistent exhaustion should speak with their trial team or a healthcare professional rather than adjusting doses alone.
What Is Retatrutide?
Retatrutide is an experimental once-weekly injection that activates three hormone receptors at the same time: GIP, GLP-1, and glucagon. That triple action is what sets it apart from earlier weight-loss medications, which target only one or two of those pathways.
Eli Lilly is developing the drug, and it does not have an approved retatrutide brand name in the United States. Any product marketed under that name outside a clinical trial is unregulated, and its contents cannot be verified.
Retatrutide is not approved by the FDA for weight loss, diabetes, or any other use. Every claim about its benefits and risks still comes from research settings rather than routine prescribing.
Why Retatrutide Can Cause Low Energy
Fatigue on retatrutide rarely has a single cause. Most people are managing several energy drains at once, which is why the symptom can feel stubborn even when the medication is working as intended.
- Large calorie deficit. Appetite suppression is the goal of the drug, but eating far less than usual limits the fuel available for daily activity.
- Rapid weight loss. Fast weight loss can shrink muscle mass and glycogen stores, both of which feed everyday energy levels.
- Glucagon receptor activity. The glucagon arm of retatrutide raises energy expenditure, which can leave some users feeling depleted.
- Gastrointestinal side effects. Nausea and vomiting make it hard to eat enough, and dehydration adds to the fatigue.
- Nutrient gaps. Low intake of protein, iron, vitamin B12, and electrolytes can produce weakness and brain fog.
- Blood sugar shifts. People taking insulin or sulfonylureas may experience more lows, and low blood sugar feels exactly like sudden exhaustion.
- Poor sleep. Nighttime nausea, reflux, or frequent bathroom trips chip away at rest.
In the Phase 2 trial published in the New England Journal of Medicine, gastrointestinal events such as nausea, diarrhea, and vomiting were the most frequent side effects, and fatigue appeared alongside them. Higher doses produced more side effects overall, which is why trials use slow step-up schedules.
How Long Does the Fatigue Last?
Low energy is usually worst in the days and weeks after starting treatment or moving to a higher dose. The answer to how long does retatrutide take to work depends on the titration schedule, and full weight-loss effects generally take several months to develop.
In the Phase 2 trial, retatrutide dosage ranged from 1 mg to 12 mg once weekly, and participants on higher doses reported more fatigue and more gastrointestinal symptoms. Many people find that energy levels improve once they hold steady at a tolerated dose for two to four weeks.
Fatigue that keeps getting worse instead of easing is not a normal adjustment pattern and deserves medical attention.
What Helps With Retatrutide Low Energy
Most practical fixes center on fuel, fluids, and muscle preservation. They do not replace medical advice, but they address the drivers behind the majority of cases.
| Energy Drain | What Helps |
|---|---|
| Eating far less than usual | Protein at every meal; 1.2 to 1.6 grams per kilogram of body weight daily is a common target in weight-loss research |
| Dehydration from vomiting or diarrhea | Two to three liters of fluid a day plus electrolyte replacement |
| Muscle and glycogen loss | Resistance training two to three times a week and adequate protein |
| Nutrient gaps | Lab checks for iron, ferritin, vitamin B12, vitamin D, and thyroid function |
| Nausea that blocks eating | Smaller low-fat meals, eating slowly, and avoiding strong smells |
| Blood sugar dips | Review insulin and sulfonylurea doses with the prescriber |
| Poor sleep | Consistent sleep schedule and a two- to three-hour gap between the last meal and bed |
Caffeine can take the edge off a slow afternoon, but using it to replace food or sleep usually backfires. Gentle movement, such as a short walk, often restores more alertness than another cup of coffee.
When Low Energy Is a Red Flag
Seek medical care promptly for fainting, chest pain, heart palpitations, confusion, or severe dizziness. A blood sugar reading below 70 mg/dL in someone taking insulin or a sulfonylurea is a medical issue, not a side effect to push through.
Persistent vomiting, signs of dehydration, severe abdominal pain, or symptoms of gallbladder problems are also reasons to contact a clinician right away. Rapid weight loss without enough protein and resistance training can cost muscle mass, and that loss is difficult to reverse.
How Retatrutide Compares to Other Weight-Loss Drugs
People researching their options frequently search cagrilintide vs retatrutide vs tirzepatide, because each drug targets a different mix of hormones. Another common comparison is survodutide vs retatrutide, which pairs a dual GLP-1 and glucagon agonist against the triple agonist.
| Drug | Hormone Targets | Status and Energy Notes |
|---|---|---|
| Retatrutide | GIP, GLP-1, glucagon | Investigational; fatigue is among the most common side effects in trials |
| Tirzepatide | GIP, GLP-1 | FDA-approved as Mounjaro and Zepbound; fatigue is reported during dose escalation |
| Cagrilintide | Amylin (studied with semaglutide as CagriSema) | Investigational; gastrointestinal side effects dominate its profile |
| Survodutide | GLP-1, glucagon | Investigational; glucagon activity raises energy expenditure in a way similar to retatrutide |
Head-to-head fatigue data do not exist for these compounds, so comparisons rely on separate trials with different designs and dosing. Low energy is not unique to retatrutide; it shows up in studies of most GLP-1-based drugs, especially during dose escalation.
Anyone weighing these options should discuss personal risk factors, current medications, and lab work with a licensed healthcare professional before making a decision.
Frequently Asked Questions
Does retatrutide make you tired?
Yes, low energy and fatigue are among the most commonly reported side effects in retatrutide clinical trials, along with nausea and other gastrointestinal symptoms. Tiredness tends to be worst during the first few weeks of treatment and after each dose increase. It usually eases as the body adjusts and food intake stabilizes.
How long does retatrutide fatigue last?
Most people notice the heaviest fatigue in the first one to three weeks after starting or increasing a dose. As nausea fades and calorie intake returns to a workable level, energy typically improves. Fatigue that lasts more than a few weeks or keeps getting worse should be evaluated by a healthcare professional.
What helps with low energy while on retatrutide?
Eating enough protein, staying hydrated, and replacing electrolytes can address the most common causes of retatrutide fatigue. Resistance training helps protect muscle mass during rapid weight loss, and lab checks for iron, vitamin B12, and thyroid function can rule out treatable deficiencies. Anyone taking insulin or sulfonylureas should ask their prescriber whether those doses need adjusting.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.